Tumor imaging and targeting potential of an Hsp70-derived 14-mer peptide

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Gehrmann, Mathias ^a   Stangl, Stefan ^a   Foulds, Gemma A ^b   Oellinger, Rupert ^a   Breuninger, Stephanie ^a   Rad, Roland ^a   Pockley, Alan G ^b   Multhoff, Gabriele ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

14 MER TUMOR PENETRATING PEPTIDE; CARBOXYFLUORESCEIN; HEAT SHOCK PROTEIN 70; PEPTIDE DERIVATIVE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY; PROTEIN BINDING;

ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; CYTOSKELETON; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING; IN VITRO STUDY; INTERNALIZATION; MCF 7 CELL LINE; MITOCHONDRIAL MEMBRANE; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR CELL; WESTERN BLOTTING; ANIMAL; CELL MEMBRANE; ENDOSOME; GENETICS; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL MEMBRANE; ENDOSOMES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICE; PROTEIN BINDING;

EID: 84937688292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105344     Document Type: Article

References (79)

1. Xin L, Cao J, Cheng H, Zeng F, Hu X, et al. (2013) Human monoclonal antibodies in cancer therapy: a review of recent developments. Front Biosci 18: 765-772.
2. Barbet J, Bardies M, Bourgeois M, Chatal JF, Cherel M, et al. (2012) Radiolabeled antibodies for cancer imaging and therapy. Methods Mol Biol 907: 681-697.
3. Baeuerle PA, Itin C (2012) Clinical experience with gene therapy and bispecific antibodies for T cell-based therapy of cancer. Curr Pharm Biotechnol 13: 1399-1408.
4. Vacchelli E, Eggermont A, Galon J, Sautes-Fridman C, Zitvogel L, et al. (2013) Trial watch: Monoclonal antibodies in cancer therapy. Oncoimmunology 2: e22789.
5. Copeland A, Younes A (2012) Current treatment strategies in Hodgkin lymphomas. Curr Opin Oncol 24: 466-474.
6. Murphy CG, Morris PG (2012) Recent advances in novel targeted therapies for HER2-positive breast cancer. Anticancer Drugs 23: 765-776.
7. Askoxylakis V, Mier W, Zitzmann S, Ehemann V, Zhang J, et al. (2006) Characterization and development of a peptide (p160) with affinity for neuroblastoma cells. J Nucl Med 47: 981-988. (Pubitemid 46939951)
8. Zitzmann S, Kramer S, Mier W, Hebling U, Altmann A, et al. (2007) Identification and evaluation of a new tumor cell-binding peptide, FROP-1. J Nucl Med 48: 965-972. (Pubitemid 46909925)
9. Kaumaya PT, Foy KC (2012) Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncol 8: 961-987.
10. Bidwell GL (2012) Peptides for cancer therapy: a drug-development opportunity and a drug-delivery challenge. Ther Deliv 3: 609-621.
11. Okarvi SM (2008) Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer. Cancer Treat Rev 34: 13-26.
12. Botzler C, Issels R, Multhoff G (1996) Heat-shock protein 72 cell-surface expression on human lung carcinoma cells in association with an increased sensitivity to lysis mediated by adherent natural killer cells. Cancer Immunol Immunother 43: 226-230. (Pubitemid 26426255)
13. Botzler C, Schmidt J, Luz A, Jennen L, Issels R, et al. (1998) Differential Hsp70 plasma-membrane expression on primary human tumors and metastases in mice with severe combined immunodeficiency. Int J Cancer 77: 942-948. (Pubitemid 28378148)
14. Multhoff G (2007) Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods 43: 229-237.
15. Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, et al. (1997) Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 158: 4341-4350. (Pubitemid 127483936)
16. Multhoff G, Botzler C, Wiesnet M, Muller E, Meier T, et al. (1995) A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 61: 272-279.
17. Lee SJ, Choi SA, Lee KH, Chung HY, Kim TH, et al. (2001) Role of inducible heat shock protein 70 in radiation-induced cell death. Cell Stress Chaperones 6: 273-281.
18. Gehrmann M, Marienhagen J, Eichholtz-Wirth H, Fritz E, Ellwart J, et al. (2005) Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ 12: 38-51. (Pubitemid 40090027)
19. Stangl S, Gehrmann M, Riegger J, Kuhs K, Riederer I, et al. (2011) Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proc Natl Acad Sci U S A 108: 733-738.
20. Stangl S, Gehrmann M, Dressel R, Alves F, Dullin C, et al. (2010) In vivo imaging of CT26 mouse tumors by using cmHsp70.1 monoclonal antibody. J Cell Mol Med 15: 874-887.
21. Broquet AH, Thomas G, Masliah J, Trugnan G, Bachelet M (2003) Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J Biol Chem 278: 21601-21606. (Pubitemid 36792559)
22. Gehrmann M, Liebisch G, Schmitz G, Anderson R, Steinem C, et al. (2008) Tumor-specific Hsp70 plasma membrane localization is enabled by the glycophospholipid Gb3. PLoS ONE 3: e1925.
23. Hantschel M, Pfister K, Jordan A, Scholz R, Andreesen R, et al. (2000) Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients. Cell Stress Chaperones 5: 438-442. (Pubitemid 32057495)
24. Multhoff G (1997) Heat shock protein 72 (HSP72), a hyperthermia-inducible immunogenic determinant on leukemic K562 and Ewing's sarcoma cells. Int J Hyperthermia 13: 39-48.
25. Pfister K, Radons J, Busch R, Tidball JG, Pfeifer M, et al. (2007) Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer 110: 926-935. (Pubitemid 47257673)
26. Gehrmann M, Schmetzer H, Eissner G, Haferlach T, Hiddemann W, et al. (2003) Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica 88: 474-476. (Pubitemid 36547137)
27. Steiner K, Graf M, Hecht K, Reif S, Rossbacher L, et al. (2006) High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis. Leukemia 20: 2076-2079. (Pubitemid 44614913)
28. Farkas B, Hantschel M, Magyarlaki M, Becker B, Scherer K, et al. (2003) Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma. Melanoma Res 13: 147-152. (Pubitemid 36583976)
29. Gehrmann M, Doss BT, Wagner M, Zettlitz KA, Kontermann RE, et al. (2011) A novel expression and purification system for the production of enzymatic and biologically active human granzyme B. J Immunol Methods 371: 8-17.
30. Gehrmann M, Stangl S, Kirschner A, Foulds GA, Sievert W, et al. (2012) Immunotherapeutic targeting of membrane-Hsp70 expressing tumors using recombinant human granzyme B. PLoS One 7: e41341.
31. Gross C, Koelch W, DeMaio A, Arispe N, Multhoff G (2003) Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. J Biol Chem 278: 41173-41181. (Pubitemid 37280943)
32. Schilling D, Gehrmann M, Steinem C, De MA, Pockley AG, et al. (2009) Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells. FASEB J 23: 2467-2477.
33. Ran FA, Hsu PD, Lin C-Y, Gootenberg JS, Konermann S, et al. (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154: 1380-1389.
34. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, et al. (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31: 827-832.
35. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
36. Manders EMM, Verbeek FJ, Aten JA (1993) Measurement of co-localization of objects in dual-colour confocal images. J Microsc 169: 375-382. (Pubitemid 23119681)
37. Bolte S, Cordelieres FP (2006) A guided tour into subcellular co-localization analysis in light microscopy. J Microsc 224: 213-232. (Pubitemid 46010930)
38. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106. (Pubitemid 41797643)
39. Li S, Zhou Y, Fan J, Cao S, Cao T, et al. (2011) Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats. Am J Pathol 179: 2822-2834.
40. Milanezi F, Leitao D, Ricardo S, Augusto I, Schmitt F (2009) Evaluation of HER2 in breast cancer: reality and expectations. Expert Opin Med Diagn 3: 607-620.
41. McGee SF, O'Connor DP, Gallagher WM (2006) Functional interrogation of breast cancer: from models to drugs. Expert Opin Drug Discov 1: 569-584.
42. Goswami T, Shah M, Isaacs C (2009) Novel molecular prognostic markers in breast cancer. Expert Opin Med Diagn 3: 523-532.
43. Thundimadathil J (2012) Cancer treatment using peptides: current therapies and future prospects. J Amino Acids 2012: 967347.
44. Condeelis J, Weissleder R (2010) In vivo imaging in cancer. Cold Spring Harb Perspect Biol 2: a003848.
45. Fani M, Maecke HR, Okarvi SM (2012) Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics 2: 481-501.
46. Fass L (2008) Imaging and cancer: a review. Mol Oncol 2: 115-152.
47. Chow JY, Li ZJ, Kei WK, Cho CH (2013) Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer. World J Gastroenterol 19: 2731-2735.
48. Zhang X, Chen J, Kang Y, Hong S, Zheng Y, et al. (2013) Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone beta 81-95 peptide show effective antitumor activity against ovarian carcinoma. Int J Pharm DOI: 10.1016/j.ijpharm.2013.06.03
49. Lim KJ, Sung BH, Shin JR, Lee YW, Kim da J, et al. (2013) A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. PLoS One 8: e66084.
50. Ma C, Yin G, You F, Wei Y, Huang Z, et al. (2013) A specific cell-penetrating peptide induces apoptosis in SKOV3 cells by down-regulation of Bcl-2. Biotechnol Lett DOI: 10.1007/s10529-013-1263-x.
51. Rodrigues M, de la Torre BG, Andreu D, Santos NC (2013) Kinetic uptake profiles of cell penetrating peptides in lymphocytes and monocytes. Biochim Biophys Acta 1830: 4554-4563.
52. Han C, Li Y, Sun M, Liu C, Ma X, et al. (2013) Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo. Artif Cells Nanomed Biotechnol DOI: 10.3109/ 21691401.2013.801848
53. Lu RM, Chen MS, Chang DK, Chiu CY, Lin WC, et al. (2013) Targeted drug delivery systems mediated by a novel peptide in breast cancer therapy and imaging. PLoS One 8: e66128.
54. Lee SA, Kim BR, Kim BK, Kim DW, Shon WJ, et al. (2013) Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine. Biomaterials DOI: 10.1016/j.biomaterials. 2013.06.015.
55. Rerole AL, Gobbo J, De Thonel A, Schmitt E, Pais de Barros JP, et al. (2011) Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy. Cancer Res 71: 484-495.
56. Kleinjung T, Arndt O, Feldmann HJ, Bockmuhl U, Gehrmann M, et al. (2003) Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy - a target for natural killer (NK) cells. Int J Radiat Oncol Biol Phys 57: 820-826. (Pubitemid 37194310)
57. Multhoff G, Botzler C, Wiesnet M, Muller E, Meier T, et al. (1995) A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 61: 272-279.
58. Steiner K, Graf M, Hecht K, Reif S, Rossbacher L, et al. (2006) High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis. Leukemia 20: 2076-2079. (Pubitemid 44614913)
59. Gehrmann M, Radons J, Molls M, Multhoff G (2008) The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress Chaperones 13: 1-10.
60. Gehrmann M, Schilling D, Molls M, Multhoff G (2010) Radiation induced stress proteins. Int J Clin Pharmacol Ther 48: 492-493.
61. Mizuno-Yamasaki E, Rivera-Molina F, Novick P (2012) GTPase networks in membrane traffic. Ann Rev Biochem 81: 637-659.
62. Stenmark H (2009) Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10: 513-525.
63. Agarraberes FA, Terlecky SR, Dice JF (1997) An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation. J Cell Biol 137: 825-834. (Pubitemid 27215505)
64. Eskelinen EL (2006) Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 27: 495-502.
65. Spang A (2009) On the fate of early endosomes. Biol Chem 390: 753-759.
66. Feng Y, Press B, Wandinger-Ness A (1995) Rab 7: an important regulator of late endocytic membrane traffic. J Cell Biol 131: 1435-1452. (Pubitemid 26001749)
67. Chen W, Feng Y, Chen D, Wandinger-Ness A (1998) Rab11 is required for trans-Golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. Mol Biol Cell 9: 3241-3257. (Pubitemid 28516634)
68. Nakatsu Y, Ma X, Seki F, Suzuki T, Iwasaki M, et al. (2013) Intracellular transport of the measles virus ribonucleoprotein complex is mediated by Rab11A-positive recycling endosomes and drives virus release from the apical membrane of polarized epithelial cells. J Virol 87: 4683-4693.
69. Gyrd-Hansen M, Nylandsted J, Jaattela M (2004) Heat shock protein 70 promotes cancer cell viability by safeguarding lysosomal integrity. Cell Cycle 3: 1484-1485. (Pubitemid 40521395)
70. Chen WH, Chen JX, Cheng H, Chen CS, Yang J, et al. (2013) A new anticancer strategy of damaging mitochondria by pro-apoptotic peptide functionalized gold nanoparticles. Chem Commun (Camb) 49: 6403-6405.
71. Ma X, Wang X, Zhou M, Fei H (2013) A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing. Adv Healthc Mater DOI: 10.1002/adhm.201300037
72. Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, et al. (2007) Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells. Mol Cancer Ther 6: 2737-2746. (Pubitemid 350058154)
73. Malhi SS, Budhiraja A, Arora S, Chaudhari KR, Nepali K, et al. (2012) Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes. Int J Pharm 432: 63-74.
74. Hilgendorf KI, Leshchiner ES, Nedelcu S, Maynard MA, Calo E, et al. (2013) The retinoblastoma protein induces apoptosis directly at the mitochondria. Genes Dev 27: 1003-1015.
75. Fager RS, Shapiro S, Litman BJ (1977) A large-scale purification of phosphatidylethanolamine, lysophosphatidylethanolamine, and phosphatidylethanolamine, and phosphatidylcholine by high performance liquid chromatography: a partial resolution of molecular species. J Lipid Res 18: 704-709. (Pubitemid 8238665)
76. Yoon TH, Kim IH (2002) Phosphatidylcholine isolation from egg yolk phospholipids by high-performance liquid chromatography. J Chromatogr A 949: 209-216. (Pubitemid 34183428)
77. Moktan S, Raucher D (2012) Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides. Int J Pept Res Ther 18: 227-237.
78. Shabaik YH, Millard M, Neamati N (2013) Mechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cells. PLoS One 8: e54346.
79. Yan X, Zhou Y, Liu S (2012) Optical imaging of tumors with copper-labeled rhodamine derivatives by targeting mitochondria. Theranostics 2: 988-998.